HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alliance Pharma Eyes OTC Acquisitions Following Strong 2021

Executive Summary

UK-based Alliance Pharma saw sales rise double-digits in 2021, with acquisitions bolstering the performance of its established brands. Going into 2022, the company says it is in a strong position to pursue M&A in the consumer health space.

You may also be interested in...



Alliance Pharma Enhances US Offering With Perrigo's Scar Treatments

Alliance Pharma has delivered on its commitment to expand its US operations with a deal for Perrigo's ScarAway and Kelo-cote brands. For Perrigo, the divestment brings its acquisition of HRA Pharma a step closer by satisfying competition concerns.

Alliance Pharma Weighing US Acquisition Opportunity

UK-based Alliance Pharma is in talks to expand its burgeoning US consumer health offering with a bolt on acquisition. 

Alliance Pharma Grows In US With Amberen Menopause Supplement

UK-based Alliance Pharma has strengthened its US offering by acquiring Biogix and its Amberen menopause supplement.

Related Content

Topics

UsernamePublicRestriction

Register

RS152122

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel